![Richard Fante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Fante
President chez
Raphaely Independent Advisors LLC
Profil
Richard Fante currently works at Raphaely Independent Advisors LLC, as President from 2013.
Mr. Fante also formerly worked at Innocoll Holdings Plc, as Chief Executive Officer & Director from 2019 to 2021, National Pharmaceutical Council, as Chairman from 2011 to 2012, Inhibikase Therapeutics, Inc., as Director from 2015 to 2018, AstraZeneca Pharmaceuticals LP, as President-United States Business from 1995 to 2013, Lederle Laboratories, as Principal, Astra USA, Inc., as Vice President-Marketing Operations, and Innocoll AG, as Chief Commercial Officer.
Mr. Fante received his undergraduate degree from Princeton University and Masters Business Admin degree from The University of North Carolina at Charlotte.
Postes actifs de Richard Fante
| Sociétés | Poste | Début |
|---|---|---|
Raphaely Independent Advisors LLC
 Raphaely Independent Advisors LLC Investment ManagersFinance Provides investment advice | President | 11/04/2013 |
Anciens postes connus de Richard Fante
| Sociétés | Poste | Fin |
|---|---|---|
| INNOCOLL HOLDINGS PLC | Directeur Général | 11/01/2021 |
| INHIBIKASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2018 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Corporate Officer/Principal | 01/03/2013 |
Innocoll AG
 Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Président | 02/11/2012 |
Formation de Richard Fante
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
National Pharmaceutical Council
National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services Operates as a not for profit organization which specializes in research development, information dissemination, education and communication of information to patients | Commercial Services |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Provides testing services | Commercial Services |
Astra USA, Inc. | |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Raphaely Independent Advisors LLC
Raphaely Independent Advisors LLC Investment ManagersFinance Provides investment advice | Finance |
Innocoll AG
Innocoll AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Choisissez Zonebourse 
